www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

US EUROPE AFRICA ASIA 中文
Business / Companies

Guilin at forefront in battle against malaria

By Wang Hongyi (China Daily) Updated: 2015-11-09 09:47

Since 2000, global mortality rates among malaria patients have dropped by 47 percent. In Africa, the rate has come down by 54 percent for adults and 58 percent for children.

GPSC has played an important role, along with major global pharmaceutical companies such as Novartis in Switzerland and Sanofi-Aventis in France, in fighting malaria.

The Chinese company was at the forefront in developing the innovative artesunate vaccine, Artsun, the first of its kind, to replace quinine injections. The WHO has compared it to the "gold standard" in the battle against malaria.

Artsun is now registered in more than 30 countries and regions and has a 90 percent market share in treating servere malaria.

During the past three years, GPSC has supplied 23.8 million units of the vaccine globally, saving more than 3.4 million people from the scourge of malaria.

"This is an innovative drug that was developed in China," Guo Guangchang, chairman of Fosun Group, said.

During the past decade, 13 anti-malaria drugs developed by GPSC have been approved by the WHO, including three which are injected and 10 in oral tablets.

The company's products account for 80 percent of China's anti-malaria drug exports.

In the first three quarters of this year, Fosun Pharmaceutical, which includes GPSC, reported revenue of 9 billion yuan ($1.41 billion), a rise of 4.76 percent compared to the same period in 2014.

Further financial details have yet to be released. The company's products include metabolism and digestive system drugs, and vaccines, as well as GPSC's brands.

"At present, Guilin Pharma is building a new manufacturing site which will comply with (international) standards," GPSC said.

"In future, we will have a production capacity of over 15 billion tablets/capsules per year to meet the needs of both domestic and global markets." the company added.

Fosun Pharmaceutical also plans to expand its research and development program by working alongside institutions and other organizations.

"There should be more cooperation with research institutes and organizations," Chen Qiyu, chairman of Fosun Pharmaceutical, said.

"This would help create a much larger platform, allowing us to do a better job globally."

Previous Page 1 2 Next Page

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 久久亚洲国产视频 | 自拍视频在线观看 | 午夜毛片视频高清不卡免费 | 亚洲综合在线观看视频 | 国产成人爱片免费观看视频 | 欧美成人影院免费观 | 久久九九精品一区二区 | 欧美三级欧美一级 | 国产95在线 | 亚洲 | 久久综合精品国产一区二区三区 | 品色堂永久免费 | 91精品久久 | 亚洲人欧洲日韩 | 欧美手机视频 | 91在线一区二区三区 | 久草手机在线观看视频 | 那里有黄色网址 | 亚洲国产欧美在线人成精品一区二区 | 亚洲三级视频在线观看 | 欧美一级成人影院免费的 | 一区二区精品在线 | 成人男女视频 | 欧美久草在线 | 日韩三级在线 | 欧美成人三级大全 | 欧美成人小视频 | 91成人影院| 免费91最新地址永久入口 | 久草免费小视频 | 成年视频国产免费观看 | 日本三级11k影院在线 | 久久久精品一区 | 最近中文字幕免费视频 | 国产免费一区二区三区免费视频 | 香蕉成人国产精品免费看网站 | 成人a免费α片在线视频网站 | 亚洲国产精品一区二区三区 | 97视频在线免费播放 | 日本aaa视频| 国产成人免费福利网站 | 在线观看国产欧美 |